Project cooperationUpdated on 28 October 2026

Biomaterials partner for Horizon Europe Cluster Health consortia: polymers, nanomaterials and nanocomposites

Associate Professor at Loughborough University, UK

Loughborough, United Kingdom

About

I am looking to join consortia that need materials expertise to turn biomedical ideas into working solutions. My group at Loughborough University designs and fabricates polymer-based nanomaterials for regenerative medicine, wound care and drug delivery, from concept and fabrication through to characterisation and in vitro testing. My expertise covers:

Nanofibrous scaffolds that support cell proliferation and cell encapsulation for tissue engineering
Advanced wound dressings incorporating antimicrobial, anti-inflammatory and essential-oil-based bioactive agents
Stimuli-responsive fibres for controlled, on-demand drug release
Tailor-made nanocomposites with tunable surface and mechanical properties, including enhanced strength, controlled wettability and adjustable degradation rates

I can contribute to projects as a work package lead or technical partner, and I welcome contact from clinical, academic and industry partners (including SMEs and medical device companies) working on infection control, chronic wound management, tissue regeneration or targeted therapies.

Topic

Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Destination 6: HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
Destination 5: HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine

Type

Partner seeks Consortium/Coordinator

Similar opportunities

Project cooperation
Processing and characterisation of porous biomaterials for health applications
- Partner seeks Consortium/Coordinator
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
- Destination 5: HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Elisa Mele
Associate Professor at Loughborough University, UK
Loughborough, United Kingdom
Project cooperation
Innovative Antimicrobial Strategies to Combat Antimicrobial Resistance: Drug Discovery, Biomaterials and Advanced Delivery Systems
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Ivana Cacciatore
ASSOCIATE PROFESSOR AT THE "G. d'ANNUNZIO" UNIVERSITY OF CHIETI-PESCARA_ITALY at G. d'Annunzio University of Chieti-Pescara
CHIETI, Italy
Project cooperation
Seeking Consortium Collaboration Partners - Offering Expertise in Computer-Aided Drug Design (CADD)
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Michail Papadourakis
Postdoctoral Researcher at Hellenic Mediterranean University at Hellenic Mediterranean University
Heraklion, Crete, Greece